首页 | 本学科首页   官方微博 | 高级检索  
检索        


PTEN expression in renal cell carcinoma and oncocytoma and prognosis
Authors:Hager Martina  Haufe Heike  Kemmerling Ralf  Mikuz Gregor  Kolbitsch Christian  Moser Patrizia L
Institution:Department of Pathology, Paracelsus Medical University, Müllner Hauptstrasse 48, A-5020 Salzburg, Austria. hager.martina@gmx.at
Abstract:AIMS: Deletion or inactivation of the tumour suppressor gene PTEN (phosphatase and tensin homologue deleted from chromosome 10) contributes to tumorigenesis in a variety of human carcinomas. The present study evaluated PTEN expression in renal cell carcinomas and oncocytomas. METHODS: A tissue microarray from 493 specimens including renal cell carcinomas (n = 440), oncocytomas (n = 21) and tumour-negative renal tissue (n = 32) from patients (n = 461) was incubated with an anti-PTEN antibody for subsequent analysis of PTEN expression. Furthermore, the effect of PTEN expression on the survival of renal carcinoma patients was evaluated. RESULTS: Renal cell carcinomas, and even more pronouncedly oncocytomas, expressed PTEN predominantly in the cytoplasm. In contrast to oncocytomas, PTEN expression was typically decreased in renal cell carcinoma subtypes. PTEN expression in sarcomatoid renal cell carcinomas was comparable to that in non-sarcomatoid subtypes. The PTEN expression pattern had no significant influence on prognosis. CONCLUSIONS: Renal tumours (renal cell carcinomas and oncocytomas) express PTEN protein predominantly in the cytoplasm. A reduction in PTEN expression appears to be an early step in renal cell carcinogenesis. However, the PTEN expression pattern of renal cell carcinomas apparently is not prognostic for patient survival.
Keywords:Renal cell carcinoma  oncocytoma  PTEN expression  cytoplasmic  nuclear  membranous  tissue microarray  survival  carcinogenesis
本文献已被 ScienceDirect PubMed 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号